In a new study published in this month’s Nature magazine, in which UTMB’s Dr. Netanya Sandler Utay served as the co-lead author, scientists were able to determine that treating SIV-infected rhesus macaques with type 1 interferon, a protein that triggers antiviral responses and inflammation, can have both beneficial and detrimental effects on the development of disease.